Richard J. Travers

1.6k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

Richard J. Travers is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Richard J. Travers has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Richard J. Travers's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Platelet Disorders and Treatments (4 papers). Richard J. Travers is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Platelet Disorders and Treatments (4 papers). Richard J. Travers collaborates with scholars based in United States, Canada and Australia. Richard J. Travers's co-authors include James H. Morrissey, Stephanie A. Smith, Kevin Croce, Rajesh A. Shenoi, Jayachandran N. Kizhakkedathu, Manu Thomas Kalathottukaren, Denisa D. Wagner, Kimberly Martinod, Naotake Tsuboi and Tanya N. Mayadas and has published in prestigious journals such as Circulation, Blood and The Journal of Immunology.

In The Last Decade

Richard J. Travers

19 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

How it all starts: Initiation of the clotting cascade

2015 338 citations Stephanie A. Smith, Richard J. Travers et al. Critical Reviews in Biochemistry and Molecular Biology profile →

Peers

Richard J. Travers

HEMAT

IMMUN

GENET

SURGE

Evi X. Stavrou United States

Thomas A. J. McKinnon United Kingdom

Sebastian Vogel Germany

Carsten Deppermann Germany

Julie Rayes United Kingdom

Andy T. Long Germany

Aya Shibamiya Germany

Pierre F. Neuenschwander United States

Bjoern F. Kraemer Germany

Katrin F. Nickel Germany

Evi X. Stavrou United States

Richard J. Travers

560 ×1.3

HEMAT

293 ×1.0

IMMUN

631 ×2.2

GENET

222 ×0.9

92 ×0.5

SURGE

Citations per year, relative to Richard J. Travers Richard J. Travers (= 1×) peers Evi X. Stavrou

Countries citing papers authored by Richard J. Travers

Since Specialization

Citations

This map shows the geographic impact of Richard J. Travers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Travers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Travers more than expected).

Fields of papers citing papers by Richard J. Travers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. Travers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Travers. The network helps show where Richard J. Travers may publish in the future.

Co-authorship network of co-authors of Richard J. Travers

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Travers. A scholar is included among the top collaborators of Richard J. Travers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Travers. Richard J. Travers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Travers, Richard J., Joshua J. Man, Qing Lu, et al.. (2025). Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke. Circulation. 152(11). 765–783.

Travers, Richard J., et al.. (2024). Abstract 110: Pro-thrombotic BCR-ABL Tyrosine Kinase Inhibitors Ponatinib And Nilotinib, But Not The Novel Agent Asciminb, Impair Endothelial Cell Wound Healing. Arteriosclerosis Thrombosis and Vascular Biology. 44(Suppl_1). 1 indexed citations

Travers, Richard J., et al.. (2024). Endothelium as a Source of Cardiovascular Toxicity From Antitumor Kinase Inhibitors. Arteriosclerosis Thrombosis and Vascular Biology. 44(10). 2143–2153. 4 indexed citations

Smith, Stephanie A., et al.. (2024). Antipolyphosphate monoclonal antibodies derived from autoimmune mice. Research and Practice in Thrombosis and Haemostasis. 8(6). 102550–102550. 1 indexed citations

Travers, Richard J., et al.. (2023). Differential vascular endothelial cell toxicity of established and novel BCR-ABL tyrosine kinase inhibitors. PLoS ONE. 18(11). e0294438–e0294438. 8 indexed citations

Camarda, Nicholas D., Richard J. Travers, Vicky K. Yang, Cheryl A. London, & Iris Z. Jaffe. (2022). VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications. Current Oncology Reports. 24(4). 463–474. 44 indexed citations

Kawakami, Ryo, Shunsuke Katsuki, Richard J. Travers, et al.. (2020). S100A9-RAGE Axis Accelerates Formation of Macrophage-Mediated Extracellular Vesicle Microcalcification in Diabetes Mellitus. Arteriosclerosis Thrombosis and Vascular Biology. 40(8). 1838–1853. 63 indexed citations

Wijeyewickrema, Lakshmi C., Emilie Lameignère, Lilian Hor, et al.. (2016). Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor. Blood. 128(13). 1766–1776. 56 indexed citations

Cines, Douglas B., Serge Yarovoi, С. В. Зайцев, et al.. (2016). Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia. Blood Advances. 1(1). 62–74. 47 indexed citations

10.

Smith, Stephanie A., Richard J. Travers, & James H. Morrissey. (2015). How it all starts: Initiation of the clotting cascade. Critical Reviews in Biochemistry and Molecular Biology. 50(4). 326–336. 338 indexed citations breakdown →

11.

Zhu, Shu, Richard J. Travers, James H. Morrissey, & Scott L. Diamond. (2015). FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow. Blood. 126(12). 1494–1502. 54 indexed citations

12.

Travers, Richard J., Stephanie A. Smith, & James H. Morrissey. (2015). Polyphosphate, platelets, and coagulation. International Journal of Laboratory Hematology. 37(S1). 31–35. 46 indexed citations

13.

Shenoi, Rajesh A., Manu Thomas Kalathottukaren, Richard J. Travers, et al.. (2014). Affinity-based design of a synthetic universal reversal agent for heparin anticoagulants. Science Translational Medicine. 6(260). 260ra150–260ra150. 79 indexed citations

14.

Travers, Richard J., Rajesh A. Shenoi, Manu Thomas Kalathottukaren, Jayachandran N. Kizhakkedathu, & James H. Morrissey. (2014). Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis. Blood. 124(22). 3183–3190. 75 indexed citations

15.

Alcaide, Pilar, Elena Maganto-García, Gail Newton, et al.. (2012). Difference in Th1 and Th17 Lymphocyte Adhesion to Endothelium. The Journal of Immunology. 188(3). 1421–1430. 42 indexed citations

16.

Smith, Stephanie A., Sharon H. Choi, Julie Collins, et al.. (2012). Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation. Blood. 120(26). 5103–5110. 98 indexed citations

17.

Chen, Kan, Hiroshi Nishi, Richard J. Travers, et al.. (2012). Endocytosis of soluble immune complexes leads to their clearance by FcγRIIIB but induces neutrophil extracellular traps via FcγRIIA in vivo. Blood. 120(22). 4421–4431. 160 indexed citations

18.

Manica, André, Júlio Flávio Meirelles Marchini, Richard J. Travers, et al.. (2011). Abstract 15820: S-Nitrosoglutathione Reductase (GSNOR) Modulates Reendothelialization and Vascular Repair. Circulation. 124. 1 indexed citations

19.

Alcaide, Pilar, Elena Maganto-García, Gail Newton, et al.. (2011). Difference in Th1 and Th17 Lymphocyte Adhesion to Endothelium. The FASEB Journal. 25. 2 indexed citations

20.

Quillard, Thibaut, Yevgenia Tesmenitsky, Kevin Croce, et al.. (2011). Selective Inhibition of Matrix Metalloproteinase-13 Increases Collagen Content of Established Mouse Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 31(11). 2464–2472. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact